Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer - Manders,P.; Tjan-Heijnen,V.C.; Span,P.N. (Cancer Res, 2004)